Objectives: The purpose of this study was to investigate whether c-Myc regulates expression of urokinase plasminogen activator (uPA) on hypoxia-induced vascular smooth muscle cells (VSMCs). Methods: VSMCs were isolated from thoracic aorta of wild-type (WT), tissue plasminogen activator (tPA) and uPA-deficient mice. Gene and protein expression levels were examined by reverse-transcription PCR and Western blotting, respectively. c-Myc and uPA transcriptional activity were determined by luciferase analysis. Zymography analysis was used to test the activity of matrix metalloproteinases (MMPs), tPA, and uPA. Results: Hypoxia significantly promoted WT and tPA −/− VSMC migration and invasion. However, uPA −/− severely decreased hypoxiainduced VSMC migration and invasion. Hypoxia increased uPA and MMP-2 activity, while uPA −/− decreased hypoxia-induced MMP-2 activity. c-Myc expression and transcriptional activity were increased in response to hypoxia, and silenced c-Myc abolished hypoxia-induced uPA and MMP-2 activity. In addition, hypoxia-induced Bcl2 expression and Bcl2 binding to c-Myc led to enhanced c-Myc-mediated uPA and MMP-2 activity in response to hypoxia.
Introduction
Atherosclerosis involves multiple processes including endothelial dysfunction, inflammation, vascular proliferation and matrix alteration. VSMC proliferation and migration into the intima after vascular injury, as well as their formation of neointima, contribute to vessel narrowing and are pivotal to the atherosclerotic process [1, 2] . One precursor of lesion development may be focal accumulation of VSMCs within the intima [3, 4] . The key stimuli for intimal hyperplasia are injury, inflammation, and increased mean wall stress [5] . Recent report shows that blood-flow cessation induces VSMC migration and invasion, resulting in intimal hyperplasia [6] . Hypoxia is involved in VSMC proliferation [7] , endothelial cell migration [8] , neovascularization [9] , and vascular remodeling [10] . Urokinase plasminogen activator (uPA) plays a significant role in vascular wound healing and arterial neointima formation after injury, most likely by affecting VSMC migration [6, 11] . Active uPA converts plasminogen into plasmin, a broadly acting protease that degrades several matrix proteins and can activate latent matrix metalloproteinases (MMPs) [12] . MMPs are associated with embryogenesis, wound healing, inflammation, arthritis, and cardiovascular diseases [13] . c-Myc is involved in the regulation of cellular proliferation, differentiation, and apoptosis [14] . Hypoxia induces cMyc expression in vivo and in vitro [15, 16] . However, it is not known whether c-Myc mediates the activity of uPA and MMP-2 in response to hypoxia. In this paper, our data show that c-Myc expression was increased on hypoxia-induced VSMCs. However, silenced c-Myc led to decreased hypoxiainduced uPA transcriptional activity, suggesting that c-Myc was required for uPA expression.
Methods

Smooth muscle cell culture
This investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1966). Deficient mice (t-PA −/− , u-PA −/− ) were generated by homologous recombination in embryonic stem cells, as described previously [17] . Experimental mice were 8-12 weeks of age. The Institutional Animal Care and Use Committee at the Kinki University School of Medicine approved the animal experiment protocols. Primary culture of wild-type (WT) and deficient mice (t-PA −/− , u-PA −/− ) aortic smooth muscle cells (SMCs) was performed as described previously [18] . Cells were placed in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin in a humidified atmosphere of 5% CO 2 and 95% air at 37°C. Hypoxic conditions were achieved by culturing VSMCs in a sealed hypoxia chamber after flushing with a mixture of 3% O 2 , 5% CO 2 , and 92% N 2 .
Cell migration and invasion assay
Cell migration and invasion were assessed using a QCM™ 24-well colorimetric cell migration assay kit (Chemicon, Temecula, CA) following the manufacturer's instructions. Cells that migrated through the polycarbonate membrane were incubated with "Cell Stain Solution" and then subsequently extracted and detected on a standard microplate reader at 560 nm. Cell invasion was assessed using the Chemicon cell invasion assay kit. This assay was performed in an invasion chamber. The inserts contain an 8-μm pore size polycarbonate membrane over which a thin layer of ECMatrix™ was dried. The extracellular matrix (ECM) layer occludes the membrane pores, blocking noninvasive cells from migrating through. Invasion cells migrate through the ECM layer and cling to the bottom of the polycarbonate membrane. The insert membrane with invaded cells on the bottom was extracted and detected on a standard microplate reader at 560 nm. 
Cell proliferation
Cell proliferation was assessed using a WST-1 kit according to the manufacturer's instructions (Roche Applied Science). This is a colorimetric assay for the quantification of cell proliferation, based on the cleavage of the tetrazolium salt WST-1 by mitochondrial dehydrogenases in viable cells. The absorbance of the sample was analyzed using a microplate reader.
Luciferase assay
VSMCs were seeded in the 6-well plate and contransfected with a c-Myc [19] or uPA [20] reporter plasmid and the pRL-CMV-Rluc or pGL2-luc control luciferase reporter vector using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), and subjected to hypoxia or normoxia for 8 h. Cells were lysed in passive lysis buffer and analyzed for firefly luciferase activity with reagents from the Luciferase Reporter Assay System (Promega, Madison, WI) using the luminometer LB96P (Berthold Japan, Tokyo, Japan).
Reverse-transcription PCR analysis
The mRNA of MMP-2 and uPA was analyzed by RT-PCR. The vascular smooth muscle cells were lysed, and total RNA was isolated by using the RNeasy Mini kit (Qiagen Sciences, Maryland) according to the manufacturer's specifications. Total RNA (0.5 μg) from each sample was reverse transcribed. RT-PCR was performed using the Excript™ TR reagent kit (TaKaRa Shuzo Co. Ltd., Kyoto, Japan). Amplified PCR products were resolved in 2% agarose gels, stained with ethidium bromide, and photographed under UV light. For PCR amplification, the following primers were used: MMP-2 forward, 5′-TGTTTACCATGGGTGG-CAATGCAG-3′. MMP-2 reverse, 5′-TGTTTGCAGA TCTCCGGAGTGACA-3′; GAPDH forward, 5′-TGCATCCTGCACCACCAACT; GAPDH reverse, 5′-AACACGGAAGG CCATGCCAG-3′; uPA primer was described previously [21] .
RNA interference
VSMCs were seeded in 6-well plates and small interfering RNA for c-Myc or Bcl2 was preformed using silencer c-Myc or Bcl2 siRNA and Silencer Transfection Kit according to the transfection protocol from the manufacturer (Santa Cruz, CA). A control siRNA (non-homologous to any known gene sequence) was used as a negative control.
Western blot and immunoprecipitation assay
VSMCs were lysed as described previously [18] . VSMCs were washed with ice-cold phosphate-buffered saline and lysed in lysis buffer as above. The indicated antibodies were immunoprecipitated as described previously [22] . The samples were subjected to 10-20% gradient SDS-PAGE, transferred to a nitrocellulose membrane, then probed by Western blot analysis with the indicated antibodies (Santa Cruz, CA) and developed by using an ECL Kit (Amersham Biosciences, Buckinghamshire, UK). 
Zymography assay
The activities of uPA and tPA were performed as described previously [23] . 10% polyacrylamide gel contained 0.55 mg/ml of bovine fibrinogen and 0.056 NIH U/ml of thrombin (Sigma, St. Louis, MO). Protein samples were electrophoresed, subsequently soaked in 2.5% Triton X-100 solution for 60 min, and then incubated in reaction buffer (0.5 M Glycine-HCl, pH 8.4) at 37°C for 24-36 h. Following development, the gel was stained with Coomassie Blue R-250 for 1 h and destained with multiple changes of destain solution (30% methanol, 10% acetic acid) until light bands appeared on a blue background.
Metalloproteinase activity assay
The metalloproteinase activity was determined utilizing gelatin substrate zymography. Samples were mixed with SDS loading buffer and incubated for 30 min at 37°C. Samples and molecular weight markers were electrophoresed in a 10% polyacrylamide gel containing 0.1% gelatin.
The gel was then washed in 2.5% Triton X-100 to remove SDS, and then was incubated at 37°C for 24-48 h in 200 mM NaCl containing 40 mM Tris-HCl and 10mM CaCl 2 (pH 7.5). After staining with Coomassie Blue R-250, gelatinases were identified as clear bands.
Results
Hypoxia induces VSMC migration and invasion
Our results show that hypoxia promoted wild-type (WT) and tPA −/− VSMC migration and invasion. However, uPA −/− significantly decreased hypoxia-mediated VSMC migration and invasion (Fig. 1A and B) . In the scrape wound-induced migration assay, our data also show that hypoxia promoted WT and tPA −/− VSMC migration. uPA −/− significantly inhibited hypoxia-induced VSMC migration (Fig. 1C) . A previous report shows that hypoxia induces VSMC proliferation [7] . Our data show that hypoxia-induced WT and gene-deficient VSMC proliferation (Fig. 1D) . The results show that uPA was involved in hypoxia-induced VSMC migration and invasion. 
Hypoxia increases uPA expression and activity
Western blot analysis shows that hypoxia time dependently increased VSMC uPA protein level ( Fig. 2A) , which was consistent with the increased uPA gene expression (Fig. 2B) . To further determine if hypoxia regulates uPA activity, zymography analysis was performed. The results suggest that hypoxia significantly enhanced the uPA activity (Fig. 2C) . However, hypoxia had no effect on tPA protein expression ( Fig. 2A) and activity (Fig. 2C). 
Hypoxia increases MMP-2 activity in association with uPA
The activation of uPA degrades several matrix proteins and can activate latent MMPs [12] . Reverse-transcription PCR analysis shows that hypoxia markedly increased MMP-2 gene expression (Fig. 3A) . Although metalloproteinase activity analysis shows that hypoxia increased the activity of MMP-2, it had no effect on MMP-9 activity (Fig. 3B) . To further analyze the interaction of uPA with MMP-2, zymography analysis was carried out. The results show that uPA −/− led to suppress MMP-2 activity on hypoxiainduced VSMCs (Fig. 3C) , indicating that hypoxia increased the uPA activity, leading to the activation of MMP-2.
c-Myc is required for uPA activity
Hypoxia significantly increased c-Myc protein expression (Fig. 4A) . To further analyze whether c-Myc regulates the activity and expression of uPA, we knocked down the c-Myc protein expression. Western blot shows that c-Myc siRNA significantly inhibited c-Myc protein expression levels (Fig. 4B) . Zymography analysis suggests that silence of cMyc resulted in decreased uPA and MMP-2 activity (Fig. 4C  and D) . The inhibition of c-Myc decreased hypoxia-induced VSMC migration and invasion ( Fig. 4E and F) , which further demonstrated that c-Myc-mediated hypoxia-induced VSMC migration and invasion. The results suggest that c-Myc was required for activation of uPA and MMP-2.
c-Myc enhances uPA transcriptional activity
The uPA luciferase analysis shows that hypoxia significantly increased uPA transcriptional activity. However, silenced c-Myc markedly decreased hypoxia-mediated uPA transcriptional activity, suggesting that c-Myc was essential for uPA transcriptional activity (Fig. 5 ).
Bcl2 enhances c-Myc transcriptional activity
To better understand the mechanism of hypoxia regulating VSMC migration and invasion, Western blot analysis shows that hypoxia-induced VSMC Bcl2 expression (Fig. 6A) . The immunoprecipitation analysis suggests that Bcl2 bound to c-Myc protein on hypoxia-induced VSMCs (Fig. 6B) . The c-Myc luciferase analysis suggests that hypoxia significantly increased c-Myc transcriptional activity, but silence of Bcl2 (Fig. 6C) decreased hypoxia-induced c-Myc transcriptional activity (Fig. 6D) . Our data show that Bcl2 binding to c-Myc enhanced hypoxia-mediated c-Myc transcriptional activity.
Bcl2 enhances c-Myc-mediated uPA activity
To further analyze the mechanism of Bcl2 association with c-Myc, zymography was performed. The results show that silence of Bcl2 decreased uPA and MMP-2 activity on hypoxia-induced VSMC (Fig. 7A and B) , resulting in decreased VSMC migration and invasion ( Fig. 7C and D) . The data show that Bcl2 binding to c-Myc enhanced c-Mycmediated VSMC migration and invasion.
Discussion
Intimal hyperplasia is associated with the invasion and proliferation of VSMCs, and is triggered and controlled by numerous stimuli [24] . Blood-flow cessation induces the migration and invasion of VSMC, resulting in intimal hyperplasia [6] . In addition, hypoxia stimulates VSMC proliferation and atherosclerotic lesions [7, 8] . In the present investigation, our data show that hypoxia increased VSMC migration and invasion, but uPA −/− significantly decreased VSMC migration and invasion. Further analysis shows that hypoxia increased uPA expression and activity. However, no such change was detected in tPA deficient VSMCs. Previous report shows that loss of uPA decreases hypoxia-induced pulmonary neointimal formation [25] , and migration and invasion of VSMC cause intimal hyperplasia [6] . Therefore, our results suggest that uPA-induced VSMC migration and invasion in response to hypoxia was responsible for intimal formation.
MMPs have been implicated in cell migration and invasion [13] , and hypoxia induces the cancer cell migration associated with the expression of MMP-2 [26] . In this paper, our results show that hypoxia significantly increased VSMC MMP-2 activity, but hypoxia had no effect on the activity of MMP-9, indicating that MMP-2 may be associated with VSMC migration and invasion in response to hypoxia. The activation of tPA and uPA converts the inactive zymogen plasminogen into the active proteinase plasmin, the latter can activate metalloproteinase activity [12, 13] . Our results show that hypoxia increased uPA and MMP-2 activity, while it is unknown whether uPA up-regulates MMP-2 activity in response to hypoxia. The gelatin zymography of uPA −/− VSMCs was performed in response to hypoxia. The results show that uPA −/− decreased hypoxia-mediated MMP-2 activity. Taken together, our results show that hypoxia activated uPA/MMP-2 pathway.
The c-Myc protein plays an important role in regulating multiple cellular processes including cell growth, proliferation, and apoptosis [27] . Hypoxia induces c-Myc expression in vivo [15] , and activates PI3K/Rho/ROCK and the c-Myc pathway [16] . MMP-2 activity is increased on hypoxiainduced endothelial cell association with cytosolic phospholipase A2 [28] . However, it is unknown whether c-Myc regulates uPA activity. Our results suggest that hypoxia significantly induced c-Myc expression. Interestingly, silenced c-Myc led to a decrease in hypoxia-induced uPA and MMP-2 activity. Further analysis shows that silenced c-Myc resulted in decreased VSMC migration and invasion, suggesting that c-Myc-mediated hypoxia-induced VSMC migration and invasion by activation of uPA and MMP-2. To better understand the mechanism by c-Myc regulating uPA activity, the luciferase analysis was carried out. The results show that silence of c-Myc decreased hypoxia-induced uPA transcriptional activity, suggesting that c-Myc increased uPA expression and activity by enhancing uPA transcriptional activity in response to hypoxia. Taken together, our results suggest that c-Myc activated the uPA/MMP-2 pathway in hypoxia-induced VSMCs, resulting in VSMC migration and invasion. Other reports show that hypoxia and HIF-1α promote growth factor-induced proliferation of human VSMCs [7] , and overexpression of c-Myc transiently increases the HIF-1α protein level [15] . Therefore, the c-Myc interaction with HIF-1α needs to be further investigated.
Bcl2 cooperation with c-Myc increases the expression, secretion, and activation of MMP-2, resulting in cell invasion [29] . For further analysis whether hypoxia induces Bcl2 expression, Western blot analysis showed that hypoxia significantly increased Bcl2 expression. The immunoprecipitation analysis suggests that Bcl2 bound to the c-Myc protein. Silenced Bcl2 decreased c-Myc transcriptional activity in response to hypoxia, suggesting Bcl2 enhanced hypoxiainduced c-Myc transcriptional activity. Further analysis shows that silenced Bcl2 decreased hypoxia-induced uPA and MMP-2 activity, resulting in decreased VSMC migration and invasion, suggesting that Bcl2 enhanced the c-Mycmediated uPA/MMP-2 signaling pathway.
In conclusion, the results suggest that hypoxia-induced the expression of c-Myc. c-Myc subsequently increased uPA expression by enhancing uPA transcriptional activity, and the activation of uPA resulted in increased MMP-2 activity, leading to VSMC migration and invasion. Therefore, hypoxia activated the c-Myc/uPA/MMP-2 pathway, resulting in VSMC migration and invasion. In addition, hypoxia promoted Bcl2 binding to the c-Myc protein, that enhanced the c-Myc-mediated uPA/MMP-2 pathway.
